岐黄工程启动高层次中医药人才培养,以实际行动落实好人才强国战略

2017-12-28 方碧陶 中国中医

12月25日,中医药传承与创新“百千万”人才工程(岐黄工程)在京启动,第四批全国中医(临床、基础)优秀人才研修项目第一期中医药经典理论培训班开班。国家卫生计生委副主任、国家中医药管理局局长王国强表示,岐黄工程是国家中医药管理局历史上首次制定的高层次人才培养专项,将以高层次人才队伍建设为抓手,带动中医药人才队伍建设和能力提升,以十九大精神为指引,大力培养符合中医药事业发展需要的各类人才。

12月25日,中医药传承与创新“百千万”人才工程(岐黄工程)在京启动,第四批全国中医(临床、基础)优秀人才研修项目第一期中医药经典理论培训班开班。国家卫生计生委副主任、国家中医药管理局局长王国强表示,岐黄工程是国家中医药管理局历史上首次制定的高层次人才培养专项,将以高层次人才队伍建设为抓手,带动中医药人才队伍建设和能力提升,以十九大精神为指引,大力培养符合中医药事业发展需要的各类人才。

岐黄工程分部署启动阶段(2017~2018年)和全面实施阶段(2018~2020年),坚持公开公正、竞争择优的方式严格选拔培养对象。到2020年,选拔造就100名中医药领军人才,遴选培养近1000名中医药优秀人才,培养培训近1万名中青年中医药骨干人才,并建设一批中医药传承与创新人才培养平台。工程以坚持服务大局、遵循规律、实践锻炼、统筹协作、机制创新为原则,以提升中医药临床服务能力和科技创新能力为核心,通过创新体制机制、优化政策环境、强化保障措施,完成着力构建中医药高层次人才队伍、着力提升中医药服务能力、着力提高中医药传承创新能力、着力加强中医药人才培养基地建设四项重点任务。

王国强指出,岐黄工程是贯彻落实中央人才发展改革,加快中医药人才队伍建设的重要举措;是实施健康中国战略,提升中医药服务能力的有力保障;是实施创新驱动发展战略,推进中医药传承创新的重要支撑。要以十九大精神为指引,把中医药人才工作摆在更加突出的位置,聚焦重点领域和关键环节,大力培养符合中医药事业发展需要的各类人才,以实际行动落实好人才强国战略。

王国强表示,岐黄工程是一个系统工程,需要医疗、科研、教育等各方面密切配合、协同作战。各省各单位要加强组织管理工作,提出自己的中医药高层次人才培养工程,上下联动,形成组合拳,共同推动高层次中医药人才队伍建设。培养对象们要在政治上进一步树立四个意识,在业务上增强传承创新、临床实践的本领。

一直致力于推动岐黄工程的国医大师路志正,勉励中医药青年人才要坚持中医理论自信,坚持中医疗效自信,坚信中医药在健康中国建设中会有更多的新作为;要强化责任担当,志存高远,脚踏实地,切实担负中医药事业发展的重任与使命;要具有奉献精神,努力提高自身的理论学术水平和服务能力,用增长的才干和本领来回报党和国家,回报社会。

国医大师孙光荣是岐黄工程第四批全国中医(临床、基础)优秀人才研修项目中医药经典理论培训班班主任。他认为,岐黄工程的启动,标志着在新形势下,中医药高层次人才培养迈入新时代。第四批研修项目的培养对象必须在认清中医药事业发展形势的基础上按时完成研修任务,在筑牢继承中医药文化传统的同时符合时代的脉动,虚心学习、博采众长,为中医药事业传承发展作出新贡献。

王国强、路志正共同为第四批全国中医(临床、基础)优秀人才研修项目中医药经典理论培训授课专家代表国医大师张学文、孙光荣、王琦,全国名中医张伯礼、严世芸,老中医药专家张炳厚、刘景源、郝万山、王键等颁发了授课专家证书。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1796796, encodeId=b84b1e96796c9, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Jan 12 15:45:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796809, encodeId=4d6a1e96809ae, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 02:45:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409258, encodeId=cab814092588c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469584, encodeId=b49e146958470, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554876, encodeId=df4815548e692, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1796796, encodeId=b84b1e96796c9, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Jan 12 15:45:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796809, encodeId=4d6a1e96809ae, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 02:45:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409258, encodeId=cab814092588c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469584, encodeId=b49e146958470, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554876, encodeId=df4815548e692, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1796796, encodeId=b84b1e96796c9, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Jan 12 15:45:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796809, encodeId=4d6a1e96809ae, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 02:45:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409258, encodeId=cab814092588c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469584, encodeId=b49e146958470, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554876, encodeId=df4815548e692, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=)]
    2017-12-30 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1796796, encodeId=b84b1e96796c9, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Jan 12 15:45:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796809, encodeId=4d6a1e96809ae, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 02:45:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409258, encodeId=cab814092588c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469584, encodeId=b49e146958470, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554876, encodeId=df4815548e692, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1796796, encodeId=b84b1e96796c9, content=<a href='/topic/show?id=490e2149e82' target=_blank style='color:#2F92EE;'>#中医药人才#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21497, encryptionId=490e2149e82, topicName=中医药人才)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Jan 12 15:45:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796809, encodeId=4d6a1e96809ae, content=<a href='/topic/show?id=0f9f2149803' target=_blank style='color:#2F92EE;'>#中医药人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21498, encryptionId=0f9f2149803, topicName=中医药人才培养)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=416347, createdName=mhzhuang@stu.e, createdTime=Sat Mar 24 02:45:00 CST 2018, time=2018-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409258, encodeId=cab814092588c, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469584, encodeId=b49e146958470, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554876, encodeId=df4815548e692, content=<a href='/topic/show?id=023b249083e' target=_blank style='color:#2F92EE;'>#人才培养#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24908, encryptionId=023b249083e, topicName=人才培养)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056914558248, createdName=jml2014, createdTime=Sat Dec 30 06:45:00 CST 2017, time=2017-12-30, status=1, ipAttribution=)]